HOME >> MEDICINE >> NEWS
First clinical data presented on latest technological advance in haemophilia a therapy

Seville, Spain, May 21, 2002 The first recombinant Factor VIII therapy for Haemophilia A prepared entirely without the use of human- or animal-derived additives was found to be bioequivalent to the current gold-standard recombinant therapy according to data presented today at the XXV International Congress of the World Federation of Hemophilia.

Baxters recombinant antihaemophilic Factor VIII protein-free method (rAHF/PFM), an investigational therapy currently in phase III clinical trials, is a new category of recombinant Factor VIII prepared entirely without the addition of any human or animal raw materials in the cell culture process, purification or final formulation.

Results from a randomized double-blind, cross-over study comparing rAHF/PFM and the control, Recombinate (recombinant antihaemophilic factor), indicate that rAHF/PFM and Recombinate rAHF are bioequivalent and should exhibit comparable hemostatic efficacy in the management of Haemophilia A.

FURTHER REDUCING THEORETICAL RISK
rAHF/PFM is being developed in response to concerns about the theoretical transmission of currently unknown viruses or diseases through the continued use of human- or animal-derived components during the production process and final formulation.

All currently available recombinant Factor VIII therapies use human or animal-derived proteins at some point in their production processes or final product formulations. To date, more than 5 billion units of Recombinate rAHF have been supplied to the haemophilia community since the first clinical study infusion was administered in 1987, and there have been no confirmed cases of disease transmission associated with its use.

However, according to a recommendation from the Medical Advisory and Scientific Council (MASAC) of the National Hemophilia Federation, "all efforts should be made to remove human albumin from recombinant Factor VIII products. Moreover, increased efforts should be made to eli
'"/>

Contact: Deborah Spak
847-948-2349
Porter Novelli
21-May-2002


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First US SARS vaccine trial opens at NIH
9. First-ever safety study of medical cannabis use in Canada launched
10. First solid evidence that the study of music promotes intellectual development
11. First medical test on CD gets good results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... to join the largest accountable care organization (ACO) in the country, the company ... this groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity ...
(Date:9/17/2019)... ... 17, 2019 , ... Dr. Perry Patel, the dentist ... the American Academy of Facial Esthetics (AAFE) to administer Botox and dermal filler ... conditions such as tooth clenching and grinding, tongue tension, temporomandibular joint disorders, commonly ...
(Date:9/17/2019)... ... September 17, 2019 , ... The Center for Information ... of the third edition of The Gift of Participation. Written by CISCRP Founder, ... families to navigate the clinical research process. The new edition offers a fresh ...
(Date:9/14/2019)... (PRWEB) , ... September 13, ... ... Society (WMIS) showcased several first-in-human studies on the detection and treatment of ... two examples of these ground-breaking studies were noninvasive detection of residual HIV ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful ... coronary artery disease as he hopes to prevent anyone from having it and to ... author John Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... Ill. (PRWEB) , ... September 17, 2019 , ... ... Illinois has joined the esteemed Haute Beauty network. , The Haute Beauty Network, ... to present Dr. Babis Rammos as a body expert and our newest addition ...
(Date:9/14/2019)... ... September 13, 2019 , ... Braun Industries, Crestline Coach Ltd, and ... service and wish him well on his retirement. Braun Industries and Crestline Coach invite ... contact them direct for inquires related to new ambulance sales and service. , ...
(Date:9/14/2019)... ... September 14, 2019 , ... ... plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County found Johnson & ... of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J talc products. ...
Breaking Medicine Technology:
Cached News: